Corporate digest

Tianjin Zhong Xin Pharmaceutical Group Corp

TIANJIN Zhong Xin Pharmaceutical Group Corp's controlling shareholder plans to carry out a mixed-ownership reform amid a Communist drive to reform state-owned enterprises, the Singapore-listed firm said on Tuesday.

But it added that Tianjin Pharmaceutical Group, which owns a 43.1 per cent stake, has not finished works such as the audit and valuation of assets and "significant uncertainties" still hang over the proposed reform.